Targeting TGF beta receptor 1 in head and neck squamous cell carcinoma.

Bernhard J JankJulia SchnoellKatharina KladnikCarmen SparrMarkus HaasElisabeth GurnhoferAlexander L LeinMarkus BrunnerLukas KennerLorenz Kadletz-WankeGregor Heiduschka

Published in: Oral diseases (2023)

expressing patients. In vitro data suggest a potential radiosensitizing effect of TGFBR1 inhibition by vactosertib.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
electronic health record
machine learning
transforming growth factor
cancer therapy
data analysis
big data
deep learning
epithelial mesenchymal transition